You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Exercise Disclosure
Kelly Thomas Patrick · SEC Form 4 · Filed Oct 16, 2026
Exercise
Calculated transaction value
$0
Kelly Thomas Patrick Chief Financial Officer
XENE
Transaction date
Oct 15, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed 1 day later
XENE daily price context
Close on/before transaction
$34.33
Oct 15, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Share Units on Common Shares
- Quantity / price
- 7,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-424428
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE | Exercise | Oct 15, 2026 | Not reported |
| Xenon Pharmaceuticals Inc. XENE Current | Exercise | Oct 15, 2026 | $0 |